Literature DB >> 17136539

Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives.

Tomasz Grzela, Agata Bialoszewska, Robert Brawura-Biskupski-Samaha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17136539     DOI： 10.1007/s00259-006-0300-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  35 in total

1.  C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.

Authors:  K Sharma; Y C Patel; C B Srikant
Journal:  Mol Endocrinol       Date:  1999-01

2.  P-glycoprotein expression influences the result of 99mTc-MIBI scintigraphy in tertiary hyperparathyroidism.

Authors:  Witold Chudzinski; Justyna Niderla; Zofia Lasiecka; Grzegorz Wilczynski; Barbara Gornicka; Aleksander Wasiutynski; Joanna Maczewska; Malgorzata Kobylecka; Leszek Krolicki; Magdalena Durlik; Ewa Nowacka; Maciej Lazarczyk; Piotr Dziunycz; Lukasz Milewski; Ireneusz Nawrot; Tomasz Grzela
Journal:  Int J Mol Med       Date:  2005-08       Impact factor: 4.101

Review 3.  Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

Authors:  J C Reubi
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

4.  Expression analysis of multidrug resistance associated genes in neuroblastomas.

Authors:  P Bader; F Schilling; M Schlaud; R Girgert; R Handgretinger; T Klingebiel; J Treuner; C Liu; D Niethammer; J F Beck
Journal:  Oncol Rep       Date:  1999 Sep-Oct       Impact factor: 3.906

5.  Organic cation transporters are determinants of oxaliplatin cytotoxicity.

Authors:  Shuzhong Zhang; Katherine S Lovejoy; James E Shima; Leah L Lagpacan; Yan Shu; Anna Lapuk; Ying Chen; Takafumi Komori; Joe W Gray; Xin Chen; Stephen J Lippard; Kathleen M Giacomini
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.

Authors:  B Shapiro; J C Sisson; B L Shulkin; M D Gross; S Zempel
Journal:  Q J Nucl Med       Date:  1995-12

Review 7.  Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

Authors:  Marion De Jong; Roelf Valkema; Francois Jamar; Larry K Kvols; Dik J Kwekkeboom; Wout A P Breeman; Willem H Bakker; Chuck Smith; Stanislas Pauwels; Eric P Krenning
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

Review 8.  Peptide receptor imaging and therapy.

Authors:  D Kwekkeboom; E P Krenning; M de Jong
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

Review 9.  Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.

Authors:  E Bombardieri; E Seregni; C Villano; A Chiti; E Bajetta
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

Review 10.  The diagnosis and medical management of advanced neuroendocrine tumors.

Authors:  Gregory A Kaltsas; G Michael Besser; Ashley B Grossman
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.